6IIO image
Deposition Date 2018-10-07
Release Date 2018-11-07
Last Version Date 2025-06-25
Entry Detail
PDB ID:
6IIO
Keywords:
Title:
Cryo-EM structure of CV-A10 native empty particle
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
3.12 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:VP1
Chain IDs:A
Chain Length:297
Number of Molecules:1
Biological Source:Coxsackievirus A10
Polymer Type:polypeptide(L)
Molecule:VP0
Chain IDs:B
Chain Length:324
Number of Molecules:1
Biological Source:Coxsackievirus A10
Polymer Type:polypeptide(L)
Molecule:VP3
Chain IDs:C
Chain Length:240
Number of Molecules:1
Biological Source:Coxsackievirus A10
Ligand Molecules
Primary Citation
Coxsackievirus A10 atomic structure facilitating the discovery of a broad-spectrum inhibitor against human enteroviruses.
Cell Discov 5 4 4 (2019)
PMID: 30652025 DOI: 10.1038/s41421-018-0073-7

Abstact

Coxsackievirus A10 (CV-A10) belongs to the Enterovirus species A and is a causative agent of hand, foot, and mouth disease. Here we present cryo-EM structures of CV-A10 mature virion and native empty particle (NEP) at 2.84 and 3.12 Å, respectively. Our CV-A10 mature virion structure reveals a density corresponding to a lipidic pocket factor of 18 carbon atoms in the hydrophobic pocket formed within viral protein 1. By structure-guided high-throughput drug screening and subsequent verification in cell-based infection-inhibition assays, we identified four compounds that inhibited CV-A10 infection in vitro. These compounds represent a new class of anti-enteroviral drug leads. Notably, one of the compounds, ICA135, also exerted broad-spectrum inhibitory effects on a number of representative viruses from all four species (A-D) of human enteroviruses. Our findings should facilitate the development of broadly effective drugs and vaccines for enterovirus infections.

Legend

Protein

Chemical

Disease

Primary Citation of related structures